UK private equity firm Kester Capital has netted an 8x return from the exit of Dutch clinical research organisation (CRO) Avania to Astorg.
Buy-and-build specialist looks for portfolio add-ons as it contemplates hitting the road for a new fund in 2023
Three existing partners will lead the California office, which is the GP’s first beyond Europe
Executive led the US GP into other alternative assets like credit; no immediate successor announced
DACH industrial technology and IT investor has set a EUR 250m target for the vehicle